Sort
21,453 grants matching “tuberculosis”
T regulatory cells and immunity in tuberculosis
$373,200Kevin B Urdahl · University Of Washington · R01 · FY2009 · AI
Biosynthesis of nucleoside antibiotics targeting bacterial translocase I
$373,108Steven Gary Van Lanen · University Of Kentucky · R01 · FY2020 · AI
Investigation of the role of bacteria in the sarcoidosis trimolecular complex
$373,077Wonder P. Drake · Vanderbilt University · R01 · FY2008 · HL
Chemical Studies in Bacterial Cell Biology
$373,069Jared Thomas Shaw · University Of California At Davis · R56 · FY2009 · AI
Structural Dynamics and Mechanochemical Coupling in Nucleoprotein Machines
$372,979Zev Bryant · Stanford University · R01 · FY2022 · GM
Investigation of the role of bacteria in the sarcoidosis trimolecular complex
$372,976Wonder P. Drake · Vanderbilt University · R01 · FY2007 · HL
Recombinant Attenuated Salmonella Vaccines for Humans
$372,974Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2008 · AI
Pathogenesis of Trypanosoma cruzi infection
$372,916Roberto Docampo · University Of Georgia · R01 · FY2014 · AI
Cell Wall Biogenesis-Target for new Anti-TB drugs
$372,915Colorado State University-Fort Collins · R01 · FY2003 · AI
Antigen exposure in utero: impacts on newborn immunity and infectious diseases
$372,888Cristiana Cairo · University Of Maryland Baltimore · R01 · FY2015 · AI
Calcium signaling in Trypanosoma brucei
$372,709Roberto Docampo · University Of Georgia · R01 · FY2014 · AI
Environmental cues and responses in tuberculosis
$372,621David G Russell · Cornell University · R01 · FY2007 · AI
Targeting matrix metalloproteinases to limit immunopathology in airborne infectio
$372,614Paul Timothy Elkington · University Of Southampton · R33 · FY2016 · AI
Testing of Standard Drugs for Mycobacterium Tuberculosis (MTB) in Animal Models for MTB
$372,598Janice Endsley · University Of Texas Med Br Galveston · N01 · FY2021 · AI
Antigen exposure in utero: impacts on newborn immunity and infectious diseases
$372,562Cristiana Cairo · University Of Maryland Baltimore · R01 · FY2016 · AI
D0CK2 in pleural fibrosis
$372,500Guoqing Qian · University Of Texas Hlth Ctr At Tyler · R01 · FY2025 · HL
Investigation of the role of bacteria in the sarcoidosis trimolecular complex
$372,498Wonder P. Drake · Vanderbilt University · R01 · FY2009 · HL
MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa
$372,482Ann M Ginsberg · International Aids Vaccine Initiative · U01 · FY2018 · AI
ROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSIS
$372,400Shabaana A. Khader · Washington University · R01 · FY2014 · HL
TUBERCULOSIS ELIMINATION AND LABORATORY
$372,376Akan Ukoeninn · Wisconsin Department Of Health Services · U52 · FY2006 · PS
Drug Interactions in Substance Abusers with HIV Infection
$372,375Gerald H. Friedland · Yale University · R01 · FY2009 · DA
Drug Interactions in Substance Abusers with HIV Infection
$372,375Gerald H. Friedland · Yale University · R01 · FY2008 · DA
TRANSMISSION OF PAUCIBACILLARY AND DRUG RESISTANT TB
$372,340Stanford University · U01 · FY2001 · AI
RATIONAL DRUG DISCOVERY FOR MAC AND M TB
$372,288Johns Hopkins University · R01 · FY2001 · AI
Real-Time Monitoring Technology for Airborne Pathogens
$372,243Mesosystems Technology, Inc. · R44 · FY2004 · AI